Changing epidemiology of systemic fungal infections
M Richardson, C Lass‐Flörl - Clinical microbiology and …, 2008 - Wiley Online Library
ABSTRACT Species of Candida and Aspergillus remain the most common causes of
invasive fungal infections, but other yeasts and filamentous fungi are emerging as significant …
invasive fungal infections, but other yeasts and filamentous fungi are emerging as significant …
Update on Candida krusei, a potential multidrug-resistant pathogen
Although Candida albicans remains the main cause of candidiasis, in recent years a
significant number of infections has been attributed to non-albicans Candida (NAC) species …
significant number of infections has been attributed to non-albicans Candida (NAC) species …
The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy
R Hachem, H Hanna, D Kontoyiannis… - … Journal of the …, 2008 - Wiley Online Library
BACKGROUND. The objective of the current retrospective study was to compare the
epidemiology of candidemia and its risk factors in patients who had hematologic …
epidemiology of candidemia and its risk factors in patients who had hematologic …
Antifungal drug resistance to azoles and polyenes
MM Canuto, FG Rodero - The Lancet infectious diseases, 2002 - thelancet.com
There is an increased awareness of the morbidity and mortality associated with fungal
infections caused by resistant fungi in various groups of patients. Epidemiological studies …
infections caused by resistant fungi in various groups of patients. Epidemiological studies …
Nosocomial fungal infections: epidemiology, infection control, and prevention
GJ Alangaden - Infectious Disease Clinics, 2011 - id.theclinics.com
Fungal infections are an increasing cause of morbidity and mortality in hospitalized patients.
This article reviews the current epidemiology of nosocomial fungal infections in adult …
This article reviews the current epidemiology of nosocomial fungal infections in adult …
Antifungal effect of high-and low-molecular-weight chitosan hydrochloride, carboxymethyl chitosan, chitosan oligosaccharide and N-acetyl-D-glucosamine against …
F Seyfarth, S Schliemann, P Elsner… - International journal of …, 2008 - Elsevier
OBJECTIVES: Generally, chitosan is a water-insoluble polyaminosaccharide with
antimicrobial activity. The antifungal activity of water-soluble low-and high-molecular-weight …
antimicrobial activity. The antifungal activity of water-soluble low-and high-molecular-weight …
Candida krusei, a Multidrug-Resistant Opportunistic Fungal Pathogen: Geographic and Temporal Trends from the ARTEMIS DISK Antifungal Surveillance Program …
MA Pfaller, DJ Diekema, DL Gibbs… - Journal of clinical …, 2008 - Am Soc Microbiol
Candida krusei is well known as a fungal pathogen for patients with hematologic
malignancies and for transplant recipients. Using the ARTEMIS Antifungal Surveillance …
malignancies and for transplant recipients. Using the ARTEMIS Antifungal Surveillance …
Candidemia at a tertiary-care hospital: epidemiology, treatment, clinical outcome and risk factors for death
A Viudes, J Peman, E Canton, P Ubeda… - European Journal of …, 2002 - Springer
The demographic, clinical and microbiological data of patients with candidemia at the"
Hopital Universitario La Fe", a tertiary-care hospital in Valencia, Spain, from 1995 to 1997 …
Hopital Universitario La Fe", a tertiary-care hospital in Valencia, Spain, from 1995 to 1997 …
[HTML][HTML] Candida glabrata Biofilms: How Far Have We Come?
Infections caused by Candida species have been increasing in the last decades and can
result in local or systemic infections, with high morbidity and mortality. After Candida …
result in local or systemic infections, with high morbidity and mortality. After Candida …
Pathogenicity and drug resistance in Candida albicans and other yeast species
N Mishra, T Prasad, N Sharma, A Payasi… - Acta microbiologica et …, 2007 - akjournals.com
Pathogenic yeasts from the genus Candida can cause serious infection in humans
particularly, in immunocompromised patients and are now recognized as major agents of …
particularly, in immunocompromised patients and are now recognized as major agents of …